Armata Pharmaceuticals, Inc. (ARMP)

Armata Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	14.76	9.29	13.52	14.85	10.29	9.65
Cash & Short-Term Investments	14.76	9.29	13.52	14.85	10.29	9.65
Cash Growth	-13.91%	-31.30%	-8.95%	44.36%	6.62%	59.94%
Other Receivables	0.76	0.74	3.36	8.53	2.99	0.56
Receivables	0.76	0.74	3.36	8.53	2.99	0.56
Prepaid Expenses	1.42	1.27	2.27	3.66	1.72	0.64
Total Current Assets	16.93	11.31	19.15	27.05	15	10.85
Property, Plant & Equipment	52.48	54.93	57.28	46.65	38.07	12.84
Goodwill	3.49	3.49	3.49	3.49	3.49	3.49
Long-Term Deferred Charges	10.26	10.26	10.26	10.26	10.26	10.26
Other Long-Term Assets	6.36	6.46	8.19	8.39	2.96	2.09
Total Assets	89.52	86.44	98.36	95.83	69.77	39.52
Accounts Payable	1.28	0.77	1.59	1.68	1.14	0.96
Accrued Expenses	2.56	3.57	4.87	6.18	2.17	1.54
Short-Term Debt	-	-	-	-	-	0.72
Current Portion of Long-Term Debt	131.08	38.95	-	-	-	-
Current Portion of Leases	4.53	4.43	9.48	17.01	1.51	1.55
Other Current Liabilities	0.5	0.53	0.52	-	-	1.94
Total Current Liabilities	139.95	48.25	16.46	24.87	4.81	6.71
Long-Term Debt	15.24	55.44	82.31	-	-	-
Long-Term Leases	26.84	27.69	28.58	31.8	36.48	10.88
Long-Term Deferred Tax Liabilities	3.08	3.08	3.08	3.08	3.08	3.08
Total Liabilities	185.1	134.46	130.43	59.75	44.37	20.66
Common Stock	0.36	0.36	0.36	0.36	0.27	0.19
Additional Paid-In Capital	281.29	279.35	276.39	275.49	227.98	198.37
Retained Earnings	-377.24	-327.74	-308.82	-239.77	-202.86	-179.7
Shareholders' Equity	-95.59	-48.02	-32.07	36.08	25.4	18.86
Total Liabilities & Equity	89.52	86.44	98.36	95.83	69.77	39.52
Total Debt	177.68	126.52	120.37	48.82	37.99	13.15
Net Cash (Debt)	-162.93	-117.22	-106.85	-33.96	-27.7	-3.5
Net Cash Per Share	-4.50	-1.98	-2.96	-0.99	-1.15	-0.21
Filing Date Shares Outstanding	36.33	36.18	36.15	36.14	30.73	24.94
Total Common Shares Outstanding	36.23	36.18	36.12	36.14	27.11	18.69
Working Capital	-123.02	-36.94	2.69	2.17	10.18	4.14
Book Value Per Share	-2.64	-1.33	-0.89	1.00	0.94	1.01
Tangible Book Value	-99.08	-51.51	-35.56	32.59	21.91	15.37
Tangible Book Value Per Share	-2.73	-1.42	-0.98	0.90	0.81	0.82
Machinery	14.82	14.29	12.83	11.27	9.02	7.68
Construction In Progress	8.2	8.3	8.1	-	-	-
Leasehold Improvements	3.8	3.8	3.45	3.45	3.42	3.42

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q